Small startup touts a PhIII success in rare 'butterfly skin' disease after an FDA hold routed shares

More than three years after getting held up by the FDA, Abeona Therapeutics is trumpeting a data drop for the rare “butterfly skin” disease. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Small start­up touts a PhI­II suc­cess in rare 'but­ter­fly skin' dis­ease af­ter an FDA hold rout­ed shares